Research Solutions Appoints Interim CFO Dave Kutil Following Departure of Bill Nurthen
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 11 2025
0mins
Should l Buy RSSS?
Source: PRnewswire
- Executive Transition: Research Solutions' CFO Bill Nurthen departed on December 10, 2025, with Dave Kutil appointed as interim CFO, ensuring continuity in financial leadership as Kutil has served as Controller since 2023 and brings over 15 years of financial leadership experience.
- Strategic Alignment: Kutil has worked closely with Nurthen, sharing the company's long-term financial vision, which is expected to facilitate a seamless transition to maintain financial stability and productivity within the organization.
- Industry Background: Prior to joining Research Solutions, Kutil held positions as Controller for Lesaffre's North American subsidiary and Director of Accounting for Badger Meter, and his extensive industry experience will help the company remain competitive in a rapidly changing market.
- Leadership Acknowledgment: CEO Roy W. Olivier expressed gratitude for Nurthen's contributions and confidence in Kutil's appointment, emphasizing his capability to fulfill the new responsibilities without impacting company operations.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RSSS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RSSS
Wall Street analysts forecast RSSS stock price to rise
3 Analyst Rating
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 2.550
Low
5.00
Averages
5.33
High
6.00
Current: 2.550
Low
5.00
Averages
5.33
High
6.00
About RSSS
Research Solutions, Inc. is a holding company, which provides cloud-based technologies to streamline the process of obtaining, managing, and creating intellectual property. The Company offers various software platforms (Platforms) that are typically sold to corporate, academic, government and individual researchers as cloud-based software-as-a-service (SaaS). Its cloud-based SaaS Platforms consist of proprietary software and Internet-based interfaces sold to customers through an annual or monthly subscription fee. It also facilitates the sale of published scientific, technical, and medical (STM)content sold as individual articles (Transactions) either stand alone or via one or more of the research Platform solutions. Its platform allows customers to initiate orders, route orders based on the lowest cost to acquire, obtain spend and usage reporting, automate authentication, and connect to in-house and third-party software systems.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

- AI Integration Innovation: Research Solutions has launched Article Galaxy MCP, allowing researchers to access scientific literature directly within existing AI environments, enhancing literature search and acquisition efficiency, thereby optimizing research workflows and improving work continuity.
- Literature Acquisition Capability: The new system is compatible with various AI tools like ChatGPT and Claude, enabling researchers to not only find literature but also act on it directly through Article Galaxy's document acquisition and rights management infrastructure, enhancing research flexibility and efficiency.
- Infrastructure Development: Article Galaxy MCP is one of four components in Research Solutions' agentic research toolkit, supporting developers and enterprises in building AI-driven research workflows tailored to specific needs while ensuring research rigor and compliance.
- Publisher Collaboration Expansion: Research Solutions maintains existing licensing relationships with several publishers and is actively discussing expanding agreements to support AI and agentic use cases, ensuring publishers retain control and compliance management over content usage in AI environments.
See More
- Investor Meeting Schedule: Research Solutions will hold 1-on-1 and small group investor meetings from March 22-24, 2026, in Dana Point, California, aimed at enhancing investor engagement and improving company transparency.
- New Toolkit Preview: The company will showcase its newly developed agentic research toolkit at the conference, which is expected to attract significant investor interest and foster future collaboration opportunities.
- Wide Industry Participation: The event will feature executives from hundreds of private and public companies across various growth sectors, including business services, healthcare, and technology, highlighting Research Solutions' significant position in the industry.
- ROTH's Service Platform: As a relationship-driven investment bank, ROTH provides capital raising, research, and advisory services, facilitating connections between growth companies and investors, further promoting Research Solutions' market expansion.
See More
- Revenue Performance: Total revenue for Q2 2026 was $11.8 million, slightly down from the previous year, while platform subscription revenue increased by approximately 14% to $5.2 million, indicating stability and growth potential in the subscription business.
- Annual Recurring Revenue: The company reported an ARR of $21.8 million, up 14% year-over-year, with B2B ARR at $15.3 million, reflecting strong market demand among enterprise clients and the potential for enhanced revenue stability moving forward.
- Margin Improvement: Gross profit for the quarter was $6.2 million, a 6% increase from the prior year, with gross margin rising to 52.4%, primarily driven by a shift towards higher-margin platforms, thereby enhancing the company's profitability.
- Strategic Transformation: Management emphasized a shift towards API and AI integration, which is expected to drive larger, stickier contracts; despite challenges from customer churn and declining B2C conversion rates, the company remains focused on product innovation and market expansion for long-term growth.
See More
- Earnings Highlights: Research Solutions reported Q2 GAAP EPS of $0.02, beating expectations by $0.01, indicating stability in profitability despite a slight decline in overall revenue.
- Revenue Performance: The company’s Q2 revenue was $11.8 million, down 0.9% year-over-year, missing market expectations by $0.36 million, which may affect investor confidence in future growth prospects.
- Executive Change: Dave Kutil has been appointed as the new CFO, replacing Bill Nurthen, and this leadership change could bring new financial strategies and management styles that may impact the company’s future financial decisions.
- Market Reaction: Although the earnings report shows an EPS beat, the revenue miss may lead to a cautious market outlook on Research Solutions' short-term performance, prompting investors to monitor future performance improvement measures.
See More
- Earnings Call Schedule: Research Solutions will hold a conference call on February 12, 2026, at 5:00 p.m. ET to discuss its Q2 fiscal 2026 financial results, which is expected to significantly impact investor sentiment.
- Market Release Information: A press release containing the financial results will follow the call, reflecting the company's commitment to transparency and information disclosure, potentially influencing investor decisions.
- Participation Instructions: Investors are advised to dial in at least 5-10 minutes prior to the start time at 1-203-518-9708 to register, ensuring smooth participation in the Q&A session and enhancing interaction with management.
- Replay Availability: The call will be available for replay after 8:00 p.m. ET on the same day until March 12, 2026, allowing investors who cannot attend live to access the information, thereby improving communication efficiency between the company and its investors.
See More
- Earnings Call Scheduled: Research Solutions will hold a conference call on February 12, 2026, at 5:00 p.m. ET to discuss its Q2 fiscal 2026 financial results, which is expected to significantly impact investor sentiment.
- Financial Results Release: A press release detailing the financial results will be issued after market close, providing critical financial data and performance metrics that will help investors assess the company's financial health.
- Participation Details: Investors are advised to dial in at least 5-10 minutes prior to the start time at 1-203-518-9708 using Conference ID RESEARCH to register, enhancing interaction with management during the Q&A session.
- Replay Availability: The conference call will be available for replay after 8:00 p.m. ET on the same day until March 12, 2026, allowing investors who cannot attend live to access the information by dialing 1-412-317-6671.
See More









